Screener
Wave Life Sciences WVE Net Change in Cash
Net Change in Cash at other companies
Other financials
Where this comes from
Reported directly by Wave Life Sciences in its filing.
Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect.
The source filing: Wave Life Sciences’s 10-Q, filed July 30, 2026.
- Filed
- Jul 30, 2026, 7:50 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-324949
| Line item | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|
| Proceeds from the ESPP | 593 | 442 |
| Net cash provided by financing activities | 2,857 | 15,848 |
| Effect of foreign exchange rates on cash, cash equivalents, and restricted cash | 119 | 101 |
| Net decrease in cash, cash equivalents, and restricted cash | (234,051) | (93,573) |
| Cash, cash equivalents, and restricted cash, beginning of period | 605,874 | 305,838 |
| Cash, cash equivalents, and restricted cash, end of period | $371,823 | $212,265 |
| Supplemental disclosure of cash flow information | ||
| Operating lease right-of-use assets obtained in exchange for operating lease liabilities (See Note 2) | $(30,015) | — |
Item 1. Financial Statements
FAQ
- What is Wave Life Sciences's net change in cash?
- Wave Life Sciences (WVE) reported net change in cash of -$176.58M in Q2 2026.
- How has Wave Life Sciences's net change in cash changed year-over-year?
- Wave Life Sciences's net change in cash decreased by 410.6% year-over-year, from -$34.58M to -$176.58M.
- What does net change in cash mean?
- Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.
Ask your AI about Wave Life Sciences's net change in cash.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude